Status:
UNKNOWN
A Novel Oral Natural Extract for the Treatment of Senile Purpura
Lead Sponsor:
Nexgen Dermatologics, Inc.
Conditions:
PURPURA
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
A randomized, double-blind, placebo controlled study to assess the safety and effectiveness of a novel oral natural extract to improve the appearance of the skin of patients with senile purpura.
Eligibility Criteria
Inclusion
- Patients with evidence of purpura on physical exam
Exclusion
- Preexisting condition that would not allow the patients to take oral calcium supplement
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT01183910
Start Date
November 1 2008
End Date
August 1 2011
Last Update
June 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Berlin Center of Medical Aesthetics
Boynton Beach, Florida, United States, 33437